論文

査読有り 国際誌
2020年

Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.

Digestion
  • Satsuki Mochizuki
  • ,
  • Tadakazu Ao
  • ,
  • Takumi Sugiura
  • ,
  • Keisuke Yonemura
  • ,
  • Takehiro Shiraishi
  • ,
  • Yoshiki Kajiwara
  • ,
  • Koichi Okamoto
  • ,
  • Eiji Shinto
  • ,
  • Yasunori Okada
  • ,
  • Hideki Ueno

101
1
開始ページ
18
終了ページ
24
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1159/000504087

BACKGROUND: Cancer tissues consist of cancer cells and stroma, the latter of which dictates cancer tissue microenvironment. We recently reported that the desmoplastic reaction (DR) pattern at the invasive front in colorectal cancer (CRC) is a promising prognostic indicator. However, the molecular mechanisms of DR formation and contribution to patients' prognosis remain unclear. SUMMARY: The tumor tissue microenvironment composed of extracellular matrix (ECM), soluble factors (growth factors/cytokine/cytokine), and stromal cells controls tumor growth and spread. Among stromal cells, cancer-associated fibroblasts (CAFs) play a key role in development of the cancer tissue microenvironment, and they are responsible for DR formation. CAFs express a disintegrin and metalloproteinases (ADAMs), which modulate cancer tissue microenvironmental factors. We isolated CAFs and normal fibroblasts from colon tissues of patients with CRC and characterized them. CAFs showed the increased expression of several ADAM species including ADAM9, ADAM10, ADAM12, and ADAM17, and the expression was further increased on the ECM-coated plates. Our in vitro and in vivo studies using CAFs and CRC cells suggest that ADAM expression is associated with the morphological DR category, and ADAMs may affect cancer malignancy through tumor proliferation in CRC. Key Message: This review summarizes the present knowledge on ADAMs in cancer and describes our recent findings regarding the molecular biological background of DR mainly by focusing on ADAMs.

リンク情報
DOI
https://doi.org/10.1159/000504087
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31722362
ID情報
  • DOI : 10.1159/000504087
  • ISSN : 0012-2823
  • PubMed ID : 31722362

エクスポート
BibTeX RIS